Now in its 2nd year, the industry-focused NMD Summit will overcome the challenges preventing neuromuscular drug developers bringing truly transformative therapeutics to market.

With an emphasis on ALS, SMA, DMD and other rare diseases, 18 expert speakers from the likes of Biogen, Audentes and PTC Therapeutics will share their insights across 3 packed days.

Join 90+ neuromuscular stakeholders at this definitive forum to exchange novel ideas, gather lessons learned and establish new collaborations.

To learn more about this event, and to register online, visit https://ter.li/bgvvh7